Physician profile
Scott E Hughes
NPI 1043210206
$1,498.52
in general payments reported to CMS, 2019-2025
16 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.17 · 2021: $40.12 · 2022: $65.22 · 2023: $469 · 2024: $513 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,202 · Education: $117 · Travel and Lodging: $21.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,201.69 |
| Education | $116.83 |
| Travel and Lodging | $21.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $366.44 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $322.96 | 2023-2025 | Puraply, Via Matrix |
| Smith+Nephew, INC. | $145.46 | 2020-2024 | Grafix, Grafix Pl |
| Convatec INC. | $110.97 | 2024 | |
| Progenacare Global, LLC | $89.10 | 2024 | |
| Medtronic, INC. | $75.71 | 2023 | Intellis Adaptivestim |
| Stryker Corporation | $73.05 | 2020-2025 | Prostep Mica, Ortholoc 3di Crosscheck |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.22 | 2022 | |
| Depuy Synthes Sales INC. | $65.11 | 2025 | Dynacord, Gryphon Orthocord, Hammerlock |
| Averitas Pharma INC. | $58.00 | 2023 | Qutenza |
| Lilly USA, LLC | $32.40 | 2023-2024 | Mounjaro |
| Horizon Therapeutics Plc | $27.18 | 2021 | |
| Trice Medical, INC. | $20.85 | 2025 | |
| Bioventus LLC | $17.97 | 2024 | Exogen Ultrasound Bone Healing System |
| Ani Pharmaceuticals, INC. | $15.16 | 2025 | Purified Cortrophin Gel |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.